论文部分内容阅读
目的:观察微血管减压术(MVD)治疗原发性三叉神经痛(PTN)的临床疗效,研究其病因及相关因素。方法:回顾性分析43例PTN患者的病例资料,总结和分析临床治疗效果及其并发症的发生。结果:43例患者治愈38例(88.37%),显效3例(6.97%),有效1例(2.33%),无效1例(2.33%);总有效率为97.67%,随访3～18个月,有1例患者复发,无严重并发症及死亡病例。结论:微血管减压术治疗原发性原发性三叉神经痛安全有效,治愈率高,复发率低,三叉神经功能可得到有效保护,是原发性三叉神经痛较多治疗方法中理想的治疗方法。
Objective: To observe the clinical efficacy of microvascular decompression (MVD) in the treatment of primary trigeminal neuralgia (PTN) and to study its etiology and related factors. Methods: A retrospective analysis of 43 cases of PTN patient data to summarize and analyze the clinical treatment of complications and its occurrence. Results: 43 patients were cured in 38 cases (88.37%), effective in 3 cases (6.97%), effective in 1 case (2.33%) and ineffective in 1 case (2.33%). The total effective rate was 97.67% , One patient relapsed, no serious complications and deaths. Conclusion: Microvascular decompression for the treatment of primary primary trigeminal neuralgia is safe and effective, with high cure rate, low recurrence rate and effective protection of the trigeminal nerve function. It is an ideal treatment for more patients with primary trigeminal neuralgia method.